Biological Basis of Cancer Therapy Part A: Molecular Biology, Chemotherapy and Pharmacology incorporating RCR FRCR 1 syllabus | Recordings

Recordings available now until September 2025

The Cancer Studies Research Group based at The Christie School of Oncology and Cancer Research UK Manchester Institute play a major role in allowing specialist registrars in clinical and medical oncology to fulfil the academic side of their training.

This programme is run as a 5-day lecture series and includes examination practice sessions. Monday to Wednesday will focus on molecular biology and immunotherapy, and Thursday and Friday will cover pharmacology and chemotherapy.

Low-to-Middle-Income Country (LMIC) course fees are offered at a 50% reduction. Countries eligible for LMIC reduced rate can be found on The World Bank website. Countries listed under the headings "Low-Income Economies" and Lower-Middle-Income Economies" will be considered.

If you are currently living in an LMIC, please email julie.edwards@cruk.manchester.ac.uk attaching proof of employment from your current hospital/institute before booking and completing registration on Eventbrite.

The teaching is designed for trainee medical and clinical oncologists and incorporates the FRCR part 1 syllabus including candidates for the Royal College FRCR part 1 examinations.

• Pharmacology and drug toxicity
• Pharmacokinetics
• Angiogenesis
• Immunotherapy and vaccines
• Cancer genetics
• Apoptosis
• Clinical pharmacology
• High dose chemotherapy
• Exam practice sessions
• Chemotherapy principles and drug resistance

The course covers FRCR part 1 examinations as part of the RCR syllabus.

The lectures and exam practise sessions have been recorded from the live teaching and are now available for viewing. Recordings will be accessible until September 2025 in line with the RCR Spring and Autumn 2025 examinations. Links to the recordings will be sent via Sharepoint upon registration.